Zimlovisertib plus tofacitinib shows greater efficacy than tofacitinib alone in reducing Disease Activity Scores in patients with moderate to severe RA at week 12.
Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.
A novel cerumen assay called the cerumenogram differentiates healthy and cancerous profiles with remarkable accuracy from tiny wax samples.
Hematologists treating older patients face complex challenges, from remembering drug interactions to tailoring individualized treatment pathways. Can AI help?
Practitioners in each profession detail the speed of regulatory challenges and changes, emphasize the importance of keeping up, and offer advice on how to do…
Starting NHS heart health assessments at 25, not 40, could help tackle soaring lifetime cardiovascular risk and reduce preventable early deaths.
The use vs nonuse of probiotics and prebiotics, alone or combined, are linked to a greater decrease in depression and anxiety symptoms, new research shows.
The three-drug pill combines telmisartan, amlodipine, and indapamide.
NPs are increasingly important to the US healthcare system, but getting the respect and recognition that should come with that role is still a challenge.
Adding Niraparib to standard therapy slows tumor growth and time to symptomatic progression in men with metastatic hormone sensitive prostate cancer.
Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.
